# Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)

> **NCT04833517** · — · UNKNOWN · sponsor: **Universität des Saarlandes** · enrollment: 500 (estimated)

## Conditions studied

- Prostate Cancer Metastatic
- Castration Resistant Prostatic Cancer
- Advanced Prostate Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04833517
- **Lead sponsor:** Universität des Saarlandes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2022-12-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04833517

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04833517, "Prospective REgistry of Targeted RadionucLide TherapY in Patients With mCRPC (REALITY Study)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04833517. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*